NASDAQ Decides to Delist WINT, a BNB Holding Company, After Stock Plummets Over 75%

On the 19th, NASDAQ announced the decision to delist biotechnology company Windtree Therapeutics (WINT) as the company's stock price failed to maintain the minimum required price of $1 per share. Trading will be suspended at the start of trading on the 21st. The company's stock price plummeted by 77.21% on the 20th. CEO Jed Ratkin confirmed the delisting decision in documents filed with the SEC (Securities and Exchange Commission) on the 20th. According to Yahoo Finance, the company's stock price has fallen by about 90% over the past month and more than 99% this year. Windtree is classified as a 'Digital Asset Financial (DAT) company' that invests in cryptocurrencies...